Clinical Benefits of Denosumab vs Zoledronate in Postmenopausal Women Previously Treated with Alendronate: A Two-Year Retrospective Study
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s533224 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ziyuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shang…. Hauptthemen laut MEDLINE: Alendronate, Denosumab, Osteoporosis, Postmenopausal, Bone Density Conservation Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republ…
- Clinical Research Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Zitieren
APA
Wang, Z., Mei, Y., Shen, L., Gu, J., Ren, N., Wang, Y., Zhang, Z., & Wang, C. (2025). Clinical Benefits of Denosumab vs Zoledronate in Postmenopausal Women Previously Treated with Alendronate: A Two-Year Retrospective Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s533224
Vancouver
Wang Z, Mei Y, Shen L, Gu J, Ren N, Wang Y, et al. Clinical Benefits of Denosumab vs Zoledronate in Postmenopausal Women Previously Treated with Alendronate: A Two-Year Retrospective Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s533224
BibTeX
@article{Wang2025,
author = {Wang, Ziyuan and Mei, Yazhao and Shen, Li and Gu, Jiemei and Ren, Na and Wang, Ya and Zhang, Zhenlin and Wang, Chun},
title = {Clinical Benefits of Denosumab vs Zoledronate in Postmenopausal Women Previously Treated with Alendronate: A Two-Year Retrospective Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s533224}
}
EUVIMED